Catabasis Pharmaceuticals, Inc. CATB
8.54 +8.54
Day range unavailable
52-week range unavailable
Valuation
P/E -5.1×
FY 2024 5y median -5.1× FY 2024
P/S 0.0×
FY 2024 5y median 0.0× FY 2024
P/B 0.0×
FY 2024 5y median 0.0× FY 2024
P/FCF 0.0×
FY 2024 5y median 0.0× FY 2024
EV/EBITDA 0.5×
FY 2024 5y median 0.5× FY 2024
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2024
FCF Yield 0.0%
FY 2024 5y median 0.0% FY 2024
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2024
ROE -29.5%
FY 2024 5y median -29.5% FY 2024
ROIC -34.4%
FY 2024 5y median -34.4% FY 2024
ROA -27.5%
FY 2024 5y median -27.5% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2024
Operating Income 0.0%
FY 2024 FY 2024
EPS (diluted) 0.0%
FY 2024 FY 2024
Free Cash Flow 0.0%
FY 2024 FY 2024
Financial Health
Current Ratio 17.5×
FY 2024 5y median 17.5× FY 2024
Quick Ratio 17.5×
FY 2024 5y median 17.5× FY 2024
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2024
Net Debt / EBITDA 0.5×
FY 2024 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31